Skip to main content
ARROWHEAD PHARMACEUTICALS, INC. logo

ARROWHEAD PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · ARWR ISIN · US04280A1007 LEI · 549300O3CSB8T7OZ3D66 US Manufacturing
Open in API
Filings indexed 1,039 across all filing types
Latest filing 2015-08-04 Interim / Quarterly Rep…
Country US United States of America
Listing US ARWR

About ARROWHEAD PHARMACEUTICALS, INC.

https://arrowheadpharma.com/

Arrowhead Pharmaceuticals, Inc. is a biotechnology company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company utilizes its proprietary RNA interference (RNAi) platform to create therapies that target disease pathways previously considered 'undruggable.' Arrowhead's development pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases. The company advances a portfolio of clinical-stage candidates designed to address significant unmet medical needs.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q3 2015
2015-08-04 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filing dated August 4, 2015, reporting the announcement of fiscal 2015 third quarter financial results for the period ended June 30, 2015. It includes a press release as an exhibit but does not contain the full financial statements or detailed financial analysis itself. The text explicitly states that the information is furnished and not filed for certain regulatory purposes, indicating it is an announcement rather than the full report. The document length is 2731 characters, which is relatively short and consistent with an earnings release announcement rather than a comprehensive interim report. Therefore, this document is best classified as an Earnings Release (ER).
2015-08-04 English
Regulatory Filings 2015
Regulatory Filings
2015-07-21 English
10-Q
Interim / Quarterly Report Q2 2015
2015-05-11 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filing dated May 11, 2015, reporting the announcement of fiscal 2015 second quarter financial results for the period ended March 31, 2015. It includes a press release as an exhibit but does not contain the full financial statements or detailed financial analysis itself. The text explicitly states that the information is furnished and not filed for certain regulatory purposes, indicating it is an announcement rather than a full report. The document length is 2698 characters, which is relatively short and consistent with an earnings release announcement rather than a comprehensive interim or annual report. Therefore, this document is best classified as an Earnings Release (ER).
2015-05-11 English
Regulatory Filings 2015
Regulatory Filings
2015-05-05 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.